Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Gastroesophageal Reflux 2Barrett Esophagus 2Zollinger-Ellison Syndrome 1Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy, Digestive System 5Aspirin 3YF 476 2Narrow Band Imaging 2Esomeprazole 2Dexlansoprazole 2Biopsy 2omeprazole, sodium bicarbonate drug combination 1chlorhexidine gluconate 1Ursodeoxycholic Acid 1Tomography, Optical Coherence 1Sunitinib 1Specimen Handling 1Radiofrequency Ablation 1Proton Pump Inhibitors 1Photochemotherapy 1Omeprazole 1Metformin 1Genes, BRCA1 1Endoscopy 1Endoscopic Mucosal Resection 1Endoscopes 1Docosahexaenoic Acids 1Dihematoporphyrin Ether 1Diagnostic Imaging 1Cryosurgery 1Contraceptive Devices, Female 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Barrett Esophagus × YF 476 × Clear all
NCT01298999 2021-11-23

Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus

Columbia University

Phase 2 Completed
27 enrolled 16 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Gastroesophageal Reflux

NCT02597712 2021-04-12

YF476 in Barrett's Esophagus

Trio Medicines Ltd.

Phase 2 Completed
27 enrolled 15 charts
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡